NGM Biopharmaceuticals Inc buy dimontalban
Start price
24.10.22
/
60%
€4.40
Target price
24.10.23
€16.00
Performance (%)
26.14%
End price
29.10.22
€5.55
Summary
This prediction ended on 29.10.22 with a price of €5.55. The BUY prediction by dimontalban finished with a performance of 26.14%. dimontalban has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| NGM Biopharmaceuticals Inc | - | - | - |
| iShares Core DAX® | 0.000% | -2.064% | 13.111% |
| iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% |
| iShares Nikkei 225® | 1.568% | -5.892% | 19.592% |
| iShares S&P 500 | 0.334% | -2.281% | 27.745% |
According to dimontalban what are the pros and cons of NGM Biopharmaceuticals Inc for the foreseeable future?
Pros
Growths faster than the competition
Sustainability is very important
Very Future proof/growth oriented business model
Could be worthwhile Investment >10% per year
Fair valuation
Standard Investments for future growth
Capable Management
Very good company culture
Innovative
Strong uniques
Differentiated customer and product portfolio
Stable Large shareholder and/or long term investor
Top 10 in its market
Known brand
Cons
Very low/no dividend yield expected
ROE lower than 10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
negative Cash Flow expected
Bad rating
High risks in the balance sheet
Increased challenges to pay loans and raise capital
High risks for its business
Significant cyclical dependencies